cabozantinib and Myeloproliferative-Disorders

cabozantinib has been researched along with Myeloproliferative-Disorders* in 1 studies

Other Studies

1 other study(ies) available for cabozantinib and Myeloproliferative-Disorders

ArticleYear
A Constitutional Activating
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-15, Volume: 25, Issue:14

    The genesis of all cancers results from an accumulation of mutations, constitutional and/or acquired when induced by external mutagenic factors. High-speed technologies for genome sequencing have completely changed the study of disease genetics, but with limited knowledge of the functional value of most genetic changes.. Here, we proposed an innovative individual approach by studying tissue samples from a young woman with an unusual association of breast cancer, polycythemia vera, and rheumatoid arthritis. We performed genomic analyses for copy number variations and point mutations on laser-microdissected tumor cells from the breast cancer, and on CD34. Using ONCOSCAN technology, we identified a constitutional pR988C, c2962C>T mutation of. Our study opens a considerable field of application in the domain of constitutional genetics, to establish genetic links between cancers and other very different severe diseases.

    Topics: Adult; Anilides; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Breast Neoplasms; Carcinoma, Squamous Cell; Chronic Disease; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Myeloproliferative Disorders; Polycythemia Vera; Proto-Oncogene Proteins c-met; Pyridines; Skin Neoplasms

2019